Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconTECHBIO-TECHNE$7.97bn43.360.63%
us flag iconCRLCharles River Laboratories International$7.84bn47.61n/a
us flag iconICLRIcon$7.79bn10.05n/a
us flag iconCYTKCytokinetics$7.70bnn/an/a
us flag iconPCVXVaxcyte$7.65bnn/an/a
us flag iconTEMTempus AI$7.62bnn/an/a
us flag iconNUVLNuvalent,$7.60bnn/an/a
us flag iconIBRXImmunitybio$7.59bnn/an/a
us flag iconMRUSMerus NV$7.35bnn/an/a
us flag iconCDTXCidara Therapeutics$6.95bnn/an/a
us flag iconACLXArcellx$6.70bnn/an/a
us flag iconRETAReata Pharmaceuticals$6.52bnn/an/a
us flag iconKYMRKymera Therapeutics$6.38bnn/an/a
us flag iconPTGXProtagonist Therapeutics$6.32bnn/an/a
us flag iconBLTEBelite Bio$5.98bnn/an/a
us flag iconTERNTerns Pharmaceuticals$5.98bnn/an/a
us flag iconCOGTCogent Biosciences$5.86bnn/an/a
us flag iconMTSRMetsera$5.58bnn/an/a
us flag iconISEEIVERIC bio$5.51bnn/an/a
us flag iconCGONCG Oncology$5.46bnn/an/a